Benefits of Rosuvastatin in Cardiovascular Protection Remain Unclear After HOPE-3.

Q3 Medicine

Review of Diabetic Studies Pub Date : 2016-01-01 Epub Date: 2017-02-10 DOI:10.1900/RDS.2016.13.212

Yu-Hung Chang, Der-Wei Hwu, Wei-Pin Kao, Yau-Jiunn Lee

引用次数: 0

Abstract Image

查看原文本刊更多论文

HOPE-3 后，瑞舒伐他汀在保护心血管方面的益处仍不明确。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Review of Diabetic Studies Medicine-Internal Medicine

CiteScore

1.80

自引率

0.00%

发文量

期刊介绍： The Review of Diabetic Studies (RDS) is the society"s peer-reviewed journal published quarterly. The purpose of The RDS is to support and encourage research in biomedical diabetes-related science including areas such as endocrinology, immunology, epidemiology, genetics, cell-based research, developmental research, bioengineering and disease management.